Topic: drug liability

A judge has ordered 1,200 Xarelto liability cases against J&J and Bayer to be prepared for trial in courts around the country.

AbbVie has scored a victory in its AndroGel legal saga as more than 4,000 cases await trial.

A judge's new ruling means the first verdict to go against Bayer and Johnson & Johnson over Xarelto's bleeding risks won't stand.

After three wins in cases over the risks of blockbuster blood thinner Xarelto, Bayer and Johnson & Johnson have encountered their first defeat.

In one legal expert's view, Johnson & Johnson will continue to take a tough stand against thousands of talc cases.

With an appeals ruling, Roche will have to head back to court to defend against Accutane liability cases.

Bristol-Myers Squibb and Pfizer are riding a hot streak defending against Eliquis liability lawsuits, prevailing in several dozen recent cases.

Johnson & Johnson and Bayer are two-for-two in defending Xarelto against liability lawsuits, but thousands more claims of bleeding injury await.

Pfizer and Bristol-Myers face three new lawsuits in New York claiming their big-selling anticoagulant Eliquis ended up hurting patients.

At least 18 federal lawsuits claiming Johnson & Johnson’s talc-based powders caused ovarian cancer could be consolidated for pretrial work, and J&J wants that litigation in New Jersey, its home state.